RL
Distinguished in Nonalcoholic Steatohepatitis (NASH)
Areas of Expertise
Check Dr. Rohit R. Loomba's experience treating your condition:
About Dr. Rohit R. Loomba

Rohit Loomba is a Gastroenterologist in San Diego, California. Loomba has been practicing medicine for over 23 years and is rated as a Distinguished expert by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). He is also highly rated in 6 other conditions, according to our data. His top areas of expertise are Nonalcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease, Cirrhosis, and Visceromegaly. He is licensed to treat patients in Maryland and California. Loomba is currently accepting new patients.

His participating in 23 clinical trials in the past 15 years. In particular, he has participated in 18 clinical trials in the study of Nonalcoholic Steatohepatitis (NASH).

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Rohit R. Loomba it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
4510 Executive Dr, San Diego, CA 92121
Other Locations
4168 Front St, San Diego, CA 92103
9350 Campus Point Dr, La Jolla, CA 92037
Background & Education
Graduate Institution
Other, 1999
Specialties
Gastroenterology
Licenses
Internal Medicine in MD
Hospital Affiliations
UC San Diego Medical Center
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


23 Clinical Trials

Alpha-1 Antitrypsin Deficiency Adult Clinical and Genetic Linkage Study
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial.
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
Complex Effects of Dietary Manipulation on Metabolic Function, Inflammation and Health
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
Vitamin E Dosing Study (VEDS): A Dose Finding Study of Vitamin E for the Treatment of Adult NAFLD
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis
A Phase 2, Multi-Center, Single-Blind, Randomized, Placebo-Controlled Study of TVB 2640 in Subjects With Non-Alcoholic Steatohepatitis (FASCINATE-1)
Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2
Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis
View 11 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Distinguished
Distinguished
Distinguished